Special Issue "Recent Advances in Obesity-Related Metabolic Diseases"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 739
The prevalence of obesity has significantly increased in the past few decades because of sedentary life styles and limited physical activity. Obesity is now considered a global epidemic disease. Obesity is a chronic disease that can cause or aggravate co-morbidities including type two diabetes mellitus (T2DM), hypertension, cardiovascular disease (CVD), metabolic dysfunction-associated steatotic liver disease (MAFLD), metabolic dysfunction-associated steatohepatitis (MASH), and certain other diseases.
The major contributor of obesity-induced metabolic dysfunction includes dysfunction of adipose tissue, liver, skeletal muscle, gut, and brain. Unfortunately, we do not have a comprehensive knowledge about these individual organs and their cross-talk during pathological conditions. Enormous research has been conducted and is also actively pursuing a search for novel targets which could be pharmacologically targeted to combat these diseases.
The Special Issue aims to summarize research studies involving obesity and associated comorbidities. The major focus is studies reporting novel pathways or targets in obesity. Translational studies including pre-clinical studies with rodents and human subjects are also encouraged in this issue.
Original research articles include (but not limited to) deciphering novel pathways with molecular mechanisms, unravelling the role of unknown or less-characterized proteins in obesity metabolism, and exploring the function of adipose tissue, liver, heart, and muscle.
Dr. Sandip Mukherjee
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- adipose tissue
- cardiovascular diseases
- new drug targets
- translational studies